Back to results
US 8,568,984 B2Granted
Methods of diagnosing non-urinary tract diseases by detecting aberrant methylation
AssigneePhiladelphia Health and Education Corporation
InventorsYing-Hsiu Su, Benjamin Song, Janet Song, Timothy M. Block
Life of this patent
Estimating the term…
Abstract
Provided are methods of diagnosing and/or determining treatment of non-urinary tract cancers by detecting biomarkers, and aberrant methylation in said biomarkers, in human urine samples.
Claims1
A method for detecting aberrant hypermethylation of the vimentin gene comprising:
- obtaining a biological sample derived from a subject;
- and
- subjecting said sample to a two-step nested real time PCR assay wherein the first PCR primer set of a forward primer having the sequence of gctcttcgtggtgtggtgcggttcgggtatcgc (SEQ ID NO:5) and a reverse primer having a sequence of gctcttcgtggtgtggtgctccGactaaaactcGacc (SEQ ID NO:6), wherein the twenty-third guanine residue and the thirty-fourth guanine residue are locked nucleic acid residues;
- and the second PCR primer set of a forward primer having the sequence of gtgtggtgcggtt (SEQ ID NO:
- 51) and a reverse primer having the sequence of gtgtggtgctccga (SEQ ID NO:
- 10), and a probe of FAM-atcgcgagtcggtcgagtt-BHQ 1(SEQ ID NO:
- 9),
- thereby determining the absence or presence of aberrant hypermethylation of the vimentin gene in said subject.
5 more elements
Dependencies are inferred from the claim text.